5-methoxytryptophan has been researched along with ST Elevation Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YH; Chou, CH; Ho, YL; Huang, CC; Hung, CS; Kuo, CC; Lee, CM; Lin, YH; Liu, LD; Wu, KK; Yeh, JF | 1 |
1 other study(ies) available for 5-methoxytryptophan and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility.
Topics: Aged; Biomarkers; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Prognosis; Prospective Studies; ROC Curve; ST Elevation Myocardial Infarction; Time Factors; Tryptophan; Ventricular Remodeling | 2016 |